{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:32:37Z","timestamp":1787023957538,"version":"build-2736575974"},"reference-count":34,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,21]]},"DOI":"10.20945\/2359-4292-2023-0095","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:15:26Z","timestamp":1708676126000},"source":"Crossref","is-referenced-by-count":4,"title":["Myxedema coma secondary to levothyroxine malabsorption in a patient previously submitted to bariatric surgery"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-6388","authenticated-orcid":false,"given":"Caterina","family":"Buoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8201-8033","authenticated-orcid":false,"given":"Maria","family":"Cavadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9257-1043","authenticated-orcid":false,"given":"Paolo","family":"Facondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0425-1726","authenticated-orcid":false,"given":"Valentina","family":"Anelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-5154","authenticated-orcid":false,"given":"Virginia","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-3187","authenticated-orcid":false,"given":"Francesca","family":"Bambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-3746","authenticated-orcid":false,"given":"Elisa","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-3451","authenticated-orcid":false,"given":"Andrea","family":"Delbarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1232","authenticated-orcid":false,"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7012-4311","authenticated-orcid":false,"given":"Ilenia","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"6","key":"key20240223081520_B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","unstructured":"Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481-93. doi: 10.1111\/j.1365-2265.1977.tb01340.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key20240223081520_B2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. doi: 10.1111\/j.1365-2265.1995.tb01894.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20240223081520_B3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","unstructured":"Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. doi: 10.1093\/bmb\/ldr030.","journal-title":"Br Med Bull"},{"issue":"2","key":"key20240223081520_B4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99. doi: 10.1210\/jcem.87.2.8182.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20240223081520_B5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/jc.2009-1977","article-title":"Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques","volume":"95","author":"Walsh","year":"2010","unstructured":"Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O\u2019Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-104. doi: 10.1210\/jc.2009-1977.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20240223081520_B6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34. doi: 10.1001\/archinte.160.4.526.","journal-title":"Arch Intern Med"},{"issue":"12","key":"key20240223081520_B7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2006.0235","article-title":"Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)","volume":"17","author":"Aoki","year":"2007","unstructured":"Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007;17(12):1211-23. doi: 10.1089\/thy.2006.0235.","journal-title":"Thyroid"},{"issue":"6","key":"key20240223081520_B8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. doi: 10.4158\/EP12280.GL.","journal-title":"Endocr Pract"},{"issue":"12","key":"key20240223081520_B9","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751. doi: 10.1089\/thy.2014.0028.","journal-title":"Thyroid"},{"key":"key20240223081520_B10","doi-asserted-by":"crossref","first-page":"1080108","DOI":"10.3389\/fendo.2022.1080108","article-title":"Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption","volume":"13","author":"Gatta","year":"2022","unstructured":"Gatta E, Bambini F, Buoso C, Gava M, Maltese V, Anelli V, et al. Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption. Front Endocrinol (Lausanne). 2022;13:1080108. doi: 10.3389\/fendo.2022.1080108.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"key20240223081520_B11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0885066607301361","article-title":"Myxedema coma","volume":"22","author":"Kwaku","year":"2007","unstructured":"Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22(4):224-31. doi: 10.1177\/0885066607301361.","journal-title":"J Intensive Care Med"},{"key":"key20240223081520_B12","author":"Centers for Disease Control and Prevention (CDC)","unstructured":"Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/106273. Accessed in: May, 2023.","journal-title":"National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes"},{"key":"key20240223081520_B13","author":"American Society for Metabolic and Bariatric Surgery (ASMBS)","unstructured":"American Society for Metabolic and Bariatric Surgery (ASMBS). Estimate of bariatric surgery numbers, 2011-2020. Available from: https:\/\/asmbs.org\/resources\/estimate-of-bariatric-surgery-numbers. Accessed in: Feb 1, 2023.","journal-title":"Estimate of bariatric surgery numbers, 2011-2020"},{"issue":"16","key":"key20240223081520_B14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2146\/ajhp151062","article-title":"Long-term pharmacotherapy considerations in the bariatric surgery patient","volume":"73","author":"Bland","year":"2016","unstructured":"Bland CM, Quidley AM, Love BL, Yeager C, McMichael B, Bookstaver PB. Long-term pharmacotherapy considerations in the bariatric surgery patient. Am J Health Syst Pharm. 2016;73(16):1230-42. doi: 10.2146\/ajhp151062.","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"key20240223081520_B15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","article-title":"Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery","volume":"23","author":"Pirola","year":"2013","unstructured":"Pirola I, Formenti AM, Gandossi E, Mittempergher F, Casella C, Agosti B, et al. Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg. 2013;23(9):1493-6. doi: 10.1007\/s11695-013-1015-y.","journal-title":"Obes Surg"},{"issue":"3","key":"key20240223081520_B16","first-page":"245","article-title":"Thyroxine malabsorption following intestinal bypass surgery","volume":"10","author":"Bevan","year":"1986","unstructured":"Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10(3):245-6.","journal-title":"Int J Obes"},{"issue":"6","key":"key20240223081520_B17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-90-6-941","article-title":"Malabsorption of thyroid hormones after jejunoileal bypass for obesity","volume":"90","author":"Azizi","year":"1979","unstructured":"Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med. 1979;90(6):941-2. doi: 10.7326\/0003-4819-90-6-941.","journal-title":"Ann Intern Med"},{"issue":"2","key":"key20240223081520_B18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11739-007-0045-7","article-title":"Myxoedema coma precipitated by diabetic ketoacidosis and neuroleptic drugs: case report in an intensive care unit","volume":"2","author":"Cappelli","year":"2007","unstructured":"Cappelli C, Stanga B, Paini A, Gandossi E, Cumetti D, Castellano M, et al. Myxoedema coma precipitated by diabetic ketoacidosis and neuroleptic drugs: case report in an intensive care unit. Intern Emerg Med. 2007;2(2):147-9. doi: 10.1007\/s11739-007-0045-7.","journal-title":"Intern Emerg Med"},{"issue":"947","key":"key20240223081520_B19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/pgmj.2003.013474","article-title":"Endocrine emergencies","volume":"80","author":"Savage","year":"2004","unstructured":"Savage MW, Mah PM, Weetman AP, Newell-Price J. Endocrine emergencies. Postgrad Med J. 2004;80(947):506-15. doi: 10.1136\/pgmj.2003.013474.","journal-title":"Postgrad Med J"},{"issue":"2","key":"key20240223081520_B20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1022985902253","article-title":"Myxedema coma","volume":"4","author":"Fliers","year":"2003","unstructured":"Fliers E, Wiersinga WM. Myxedema coma. Rev Endocr Metab Disord. 2003;4(2):137-41. doi: 10.1023\/a:1022985902253.","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"key20240223081520_B21","first-page":"2485","article-title":"Myxedema coma: diagnosis and treatment","volume":"62","author":"Wall","year":"2000","unstructured":"Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485-90.","journal-title":"Am Fam Physician"},{"key":"key20240223081520_B22","volume-title":"StatPearls","author":"Elshimy","year":"2022","unstructured":"Elshimy G, Chippa V, Correa R. Myxedema. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"5","key":"key20240223081520_B23","article-title":"Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease","volume":"14","author":"Wiggins","year":"2022","unstructured":"Wiggins B, Knight KT, Banno F, Minaudo M. Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease. Cureus. 2022;14(5):e25491. doi: 10.7759\/cureus.25491.","journal-title":"Cureus"},{"key":"key20240223081520_B24","doi-asserted-by":"crossref","first-page":"bcr2018226503","DOI":"10.1136\/bcr-2018-226503","article-title":"Polyglandular endocrine emergency: lessons from a patient, which a book cannot teach","volume":"2018","author":"Ahmad","year":"2018","unstructured":"Ahmad S, Giannopoulou A, Owen P, Kalhan A. Polyglandular endocrine emergency: lessons from a patient, which a book cannot teach. BMJ Case Rep. 2018:2018:bcr2018226503. doi: 10.1136\/bcr-2018-226503.","journal-title":"BMJ Case Rep"},{"key":"key20240223081520_B25","first-page":"21","article-title":"Myxoedema coma caused by immunotherapy-related thyroiditis and enteritis","volume":"2021","author":"Mc Donald","year":"2021","unstructured":"Mc Donald D, Goulden E, Cullen G, Crown J, Crowley RK. Myxoedema coma caused by immunotherapy-related thyroiditis and enteritis. Endocrinol Diabetes Metab Case Rep. 2021;2021:21-0130. doi: 10.1530\/EDM-21-0130.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"key20240223081520_B26","first-page":"1316724","article-title":"Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation","volume":"2016","author":"Reardon","year":"2016","unstructured":"Reardon DP, Yoo PS. Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation. Case Rep Endocrinol. 2016;2016:1316724. doi: 10.1155\/2016\/1316724.","journal-title":"Case Rep Endocrinol"},{"issue":"19","key":"key20240223081520_B27","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","article-title":"Medication and nutrient administration considerations after bariatric surgery","volume":"63","author":"Miller","year":"2006","unstructured":"Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63(19):1852-7. doi: 10.2146\/ajhp060033.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"key20240223081520_B28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","article-title":"A systematic review of drug absorption following bariatric surgery and its theoretical implications","volume":"11","author":"Padwal","year":"2010","unstructured":"Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11(1):41-50. doi: 10.1111\/j.1467-789X.2009.00614.x.","journal-title":"Obes Rev"},{"issue":"2","key":"key20240223081520_B29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.2015.0422","article-title":"A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study","volume":"26","author":"Cappelli","year":"2016","unstructured":"Cappelli C, Pirola I, Daffini L, Formenti A, Iacobello C, Cristiano A, et al. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study. Thyroid. 2016;26(2):197-202. doi: 10.1089\/thy.2015.0422.","journal-title":"Thyroid"},{"issue":"6","key":"key20240223081520_B30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40618-014-0082-9","article-title":"Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube","volume":"37","author":"Pirola","year":"2014","unstructured":"Pirola I, Daffini L, Gandossi E, Lombardi D, Formenti A, Castellano M, et al. Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube. J Endocrinol Invest. 2014;37(6):583-7. doi: 10.1007\/s40618-014-0082-9.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key20240223081520_B31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11695-016-2247-4","article-title":"TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation","volume":"27","author":"Fallahi","year":"2017","unstructured":"Fallahi P, Ferrari SM, Camastra S, Politti U, Ruffilli I, Vita R, et al. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation. Obes Surg. 2017;27(1):78-82. doi: 10.1007\/s11695-016-2247-4.","journal-title":"Obes Surg"},{"issue":"3","key":"key20240223081520_B32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12020-016-1167-3","article-title":"Tablet and oral liquid L-thyroxine formulation in the treatment of na\u00efve hypothyroid patients with Helicobacter pylori infection","volume":"57","author":"Ribichini","year":"2017","unstructured":"Ribichini D, Fiorini G, Repaci A, Castelli V, Gatta L, Vaira D, et al. Tablet and oral liquid L-thyroxine formulation in the treatment of na\u00efve hypothyroid patients with Helicobacter pylori infection. Endocrine. 2017;57(3):394-401. doi: 10.1007\/s12020-016-1167-3.","journal-title":"Endocrine"},{"key":"key20240223081520_B33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12876-016-0439-y","article-title":"Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series","volume":"16","author":"Fallahi","year":"2016","unstructured":"Fallahi P, Ferrari SM, Ruffilli I, Antonelli A. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series. BMC Gastroenterol. 2016;16:22. doi: 10.1186\/s12876-016-0439-y.","journal-title":"BMC Gastroenterol"},{"key":"key20240223081520_B34","doi-asserted-by":"crossref","first-page":"633587","DOI":"10.3389\/fendo.2021.633587","article-title":"The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine","volume":"12","author":"Antonelli","year":"2021","unstructured":"Antonelli A, Elia G, Ragusa F, Paparo SR, Cavallini G, Benvenga S, et al. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine. Front Endocrinol (Lausanne). 2021;12:633587. doi: 10.3389\/fendo.2021.633587.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:15:44Z","timestamp":1708676144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/myxedema-coma-secondary-to-levothyroxine-malabsorption-in-a-patient-previously-submitted-to-bariatric-surgery\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"alternative-id":["10.20945\/2359-4292-2023-0095"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0095","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230095"}}